These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31864939)

  • 1. Timing of adjuvant chemotherapy and overall survival following radical cystectomy.
    Jue JS; Koru-Sengul T; Miao F; Kroeger ZA; Moore KJ; Alameddine M; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
    Urol Oncol; 2020 Mar; 38(3):75.e15-75.e22. PubMed ID: 31864939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013.
    Bateni ZH; Pearce SM; Zainfeld D; Ballas L; Djaladat H; Schuckman AK; Daneshmand S
    Eur Urol Oncol; 2020 Jun; 3(3):343-350. PubMed ID: 31317867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity-matched analysis of stage-specific efficacy of adjuvant chemotherapy for bladder cancer.
    Chen FV; Koru-Sengul T; Miao F; Jue JS; Alameddine M; Dave DJ; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
    Urol Oncol; 2019 Dec; 37(12):877-885. PubMed ID: 31420159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy.
    Zargar-Shoshtari K; Kongnyuy M; Sharma P; Fishman MN; Gilbert SM; Poch MA; Pow-Sang JM; Spiess PE; Zhang J; Sexton WJ
    World J Urol; 2016 Nov; 34(11):1567-1573. PubMed ID: 27072536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic value of adjuvant and neoadjuvant chemotherapy in total cystectomy for locally advanced bladder cancer].
    Habuchi T; Kakehi Y; Terachi T; Ogawa O; Yoshida O
    Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):809-17. PubMed ID: 10565159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.
    Baumann BC; Guzzo TJ; He J; Keefe SM; Tucker K; Bekelman JE; Hwang WT; Vaughn DJ; Malkowicz SB; Christodouleas JP
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):81-8. PubMed ID: 22543204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder.
    Kaushik D; Frank I; Boorjian SA; Cheville JC; Eisenberg MS; Thapa P; Tarrell RF; Thompson RH
    Int J Urol; 2015 Jun; 22(6):549-54. PubMed ID: 25761779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of adjuvant chemotherapy in locally advanced bladder cancer.
    Haque W; Lewis GD; Verma V; Darcourt JG; Butler EB; Teh BS
    Acta Oncol; 2018 Apr; 57(4):509-515. PubMed ID: 29226744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
    Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
    Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
    Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database.
    Fischer-Valuck BW; Rao YJ; Rudra S; Przybysz D; Germino E; Samson P; Baumann BC; Gay H; Michalski J
    J Urol; 2018 Feb; 199(2):416-423. PubMed ID: 28842247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.
    Shimizu F; Muto S; Taguri M; Ieda T; Tsujimura A; Sakamoto Y; Fujita K; Okegawa T; Yamaguchi R; Horie S
    Int J Urol; 2017 May; 24(5):367-372. PubMed ID: 28281310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Benefit Persists With Delayed Initiation of Adjuvant Chemotherapy Following Radical Cystectomy for Locally Advanced Bladder Cancer.
    Corbett CJ; Xia L; Mamtani R; Malkowicz SB; Guzzo TJ
    Urology; 2019 Oct; 132():143-149. PubMed ID: 31199968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy.
    Oh JJ; Kang MY; Jo JK; Lee HM; Byun SS; Lee SE; Lee S; Hong SK
    Int J Urol; 2015 Dec; 22(12):1112-7. PubMed ID: 26290403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival.
    Grunewald CM; Henn A; Galsky MD; Plimack ER; Harshman LC; Yu EY; Crabb SJ; Pal SK; Alva AS; Powles T; De Giorgi U; Agarwal N; Bamias A; Ladoire S; Necchi A; Vaishampayan UN; Sternberg CN; Bellmunt J; Baniel J; Niegisch G
    Urol Oncol; 2020 Dec; 38(12):934.e1-934.e9. PubMed ID: 32660788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neoadjuvant chemotherapy in patients undergoing radical cystectomy for muscle-invasive bladder cancer: a retrospective, multi-institutional study.
    Nitta M; Kuroda S; Nagao K; Higure T; Zakoji H; Miyakita H; Usui Y; Hasegawa M; Kawamura Y; Shoji S; Miyajima A
    Jpn J Clin Oncol; 2020 Jan; 50(1):73-79. PubMed ID: 31612911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.
    Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA.
    Hanna N; Trinh QD; Seisen T; Vetterlein MW; Sammon J; Preston MA; Lipsitz SR; Bellmunt J; Menon M; Choueiri TK; Abdollah F
    Eur Urol Oncol; 2018 May; 1(1):83-90. PubMed ID: 31100232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.